Metraipolis › archive › dc_4acc672ec4b5

Elucidating the Mechanism of Oridonin in Treating Hepatocellular Carcinoma: Network Pharmacology and Experimental Validation — Europe PMC PMID:42233527

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42233527
DOI
10.1111/jcmm.71180
License (as archived)
solo-consultazione
Archived
2026-10-07T21:37:55.023Z
SHA-256 of the archived text
cfe0c07db71e43d30a55ac43ea84a8b0d5c0119a62942f6bc0def4da59fe71e8
Stable URL of this page
https://metraipolis.com/documento/dc_4acc672ec4b5

How to cite

Elucidating the Mechanism of Oridonin in Treating Hepatocellular Carcinoma: Network Pharmacology and Experimental Validation — Europe PMC PMID:42233527 — Europe PMC (en), https://europepmc.org/article/MED/42233527 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4acc672ec4b5 (Metraipolis archive dc_4acc672ec4b5, sha256 cfe0c07db71e43d30a55ac43ea84a8b0d5c0119a62942f6bc0def4da59fe71e8)
BibTeX
@misc{dc4acc672ec4b5,
  title = {Elucidating the Mechanism of Oridonin in Treating Hepatocellular Carcinoma: Network Pharmacology and Experimental Validation — Europe PMC PMID:42233527},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42233527},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4acc672ec4b5; sha256 cfe0c07db71e43d30a55ac43ea84a8b0d5c0119a62942f6bc0def4da59fe71e8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42233527. Agents can read the archived copy with the MCP tool read_document.